$0.348500
-0.0034-0.97%
Last update: 3:27 PM
15 minutes delayed
Comments
Loading...
IGC Pharma (AMEX:IGC) Stock, Earnings Estimates, EPS, And Revenue
IGC Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 11
EPS Estimate
$-0.030
Quarterly Revenue Estimate
$310K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$1.1M
Analyze the earnings history of IGC Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
IGC Pharma (IGC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-08 | $-0.03 | $-0.04 | 25.0 % |
| Mar 2024 | 2024-06-24 | $-0.04 | $-0.04 | 0.00 % |
IGC Pharma (IGC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-08 | $272.00K | $620.00K | -56.1 % |
| Mar 2024 | 2024-06-24 | $295.00K | $190.00K | 55.3 % |
FAQ
When is IGC Pharma (AMEX:IGC) reporting earnings?
IGC Pharma (IGC) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 8, 2024 for Q1.
What were the latest earnings per share (EPS) for IGC Pharma (AMEX:IGC)?
The Actual EPS was $-0.03, which beat the estimate of $-0.04.
What were IGC Pharma’s (AMEX:IGC) revenues?
The Actual Revenue was $272K, which missed the estimate of $620K.
Browse earnings estimates, EPS, and revenue on all stocks.